David Archuletas Bestselling Memoir Devout Spurs Publishing Sector Interest in Faith and Identity Narratives Morrisons Plans to Close 100 Stores Cites Government Policy Costs as Key Factor Wall Street Rallies as Dow Sets New Record High on Middle East Optimism Lidl Surpasses Morrisons to Claim FifthPlace Spot in UK Grocery Market Robinhood Integrates AI Agents for Automated Trading and Credit Card Payments Fed Rate Hike Odds Rising Prediction Markets Point to July 2027 Increase Globus Medical Inc GMED Q1 2026 Earnings Strong EPS Beat Drives Modest Share Gains HBANL Q1 2026 Earnings Preferred Shares Report EPS Miss but Stock Edges Higher Quanterix QTRX Q1 2026 Earnings EPS Surprises Significantly to the Upside Stock Rises EVI Q1 2026 Earnings Significant EPS Miss Drags Stock Lower DSGR Q1 2026 Earnings EPS Exceeds Estimates Despite Stock Decline OMER Q1 2026 Earnings EPS Beats Estimates as Operating Expenses Decline But Stock Falls on Lack of Revenue FACT II Acquisition Corp Holds Steady Near Resistance as SPAC Market Awaits Catalyst Quantumsphere Acquisition Units Edge Lower as Consolidation Persists Near Support Cerence Inc CRNC Gains 328 Testing Resistance Near 12 Brookfield Renewable Partners BEP Surges 249 Renewable Momentum and Key Technical Levels Apex Treasury Corporation APXT Edges Higher Amid Tight Trading Range UnitedHealth Groups Managed Care Strength Drives Gains Amid Broader Economic Uncertainty MRVL Q1 2026 Earnings Slight EPS Miss Despite Positive Market Response Allarity Therapeutics ALLR Hovers Near Support as Mild Pullback Tests Key Levels SIRI Q1 2026 Earnings EPS Beat Amid Subscriber Headwinds NACCO Industries NC Q1 2026 Earnings EPS of 117 Reported Amid Limited Disclosure CREX Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines Expion360 Inc XPON Q2 2025 Earnings NarrowerThanExpected Loss on Improved Operating Efficiency National Research Corporation NRC Q1 2026 Earnings EPS of 021 Reported Stock Edges Higher Amid Limited Disclosures HLIT Q1 2026 Earnings EPS Surges Past Expectations Stock Jumps Nearly 20 ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains